|
GB8730011D0
(en)
*
|
1987-12-23 |
1988-02-03 |
Smithkline Dauelsberg |
Pharmaceutical compositions
|
|
US5096716A
(en)
*
|
1988-09-01 |
1992-03-17 |
Alza Corporation |
Dosage form for administering calcium antagonist nicardipine
|
|
US5108756A
(en)
*
|
1989-01-12 |
1992-04-28 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
|
US5186942A
(en)
*
|
1989-01-30 |
1993-02-16 |
Alza Corporation |
Nicardipine therapy
|
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
|
DE4101873C2
(de)
*
|
1991-01-23 |
1993-12-09 |
Isis Pharma Gmbh |
Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
|
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
|
AU2757392A
(en)
*
|
1991-10-24 |
1993-05-21 |
Insutech, Incorporated |
Gas pressure driven infusion system by hydrogel electrolysis
|
|
US5688518A
(en)
*
|
1992-02-27 |
1997-11-18 |
Alza Corporation |
Antidepressive therapy
|
|
US5246711A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating dysthymia
|
|
US5246710A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating cyclothymia
|
|
US5858407A
(en)
*
|
1992-02-27 |
1999-01-12 |
Alza Corporation |
Method for administering tandospirone
|
|
US5330762A
(en)
*
|
1992-02-27 |
1994-07-19 |
Alza Corporation |
Tandospiaine antidepressive therapy
|
|
US5185158A
(en)
*
|
1992-02-27 |
1993-02-09 |
Alza Corporation |
Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
|
|
US5462741A
(en)
*
|
1992-08-06 |
1995-10-31 |
Alza Corporation |
High agent loaded controlled release dispenser
|
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
|
US6919373B1
(en)
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
|
US6203813B1
(en)
|
1997-01-13 |
2001-03-20 |
Lance L. Gooberman |
Pharmaceutical delivery device and method of preparation therefor
|
|
US5951538A
(en)
*
|
1997-08-07 |
1999-09-14 |
Ceramatec, Inc. |
Gas generating device for delivering beneficial agents to a body cavity
|
|
US6645192B2
(en)
*
|
1998-09-30 |
2003-11-11 |
Ivy Animal Health, Inc. |
Pellet implant system for immediate and delayed release of antiparasitic drug
|
|
US6706282B1
(en)
|
1998-11-02 |
2004-03-16 |
Evangeline Cruz |
Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
|
|
AU1238500A
(en)
*
|
1998-11-02 |
2000-05-22 |
Alza Corporation |
Controlled delivery of active agents
|
|
US6797283B1
(en)
|
1998-12-23 |
2004-09-28 |
Alza Corporation |
Gastric retention dosage form having multiple layers
|
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
|
US6491683B1
(en)
|
1999-09-07 |
2002-12-10 |
Alza Corporation |
Osmotic dosage form composed of an extruded polymer tube form
|
|
IL150239A0
(en)
*
|
1999-12-16 |
2002-12-01 |
Alza Corp |
Dosage forms having a barrier layer to laser ablation
|
|
BR0309620A
(pt)
*
|
2002-04-29 |
2005-03-15 |
Alza Corp |
Métodos e formas de dosagem para liberação controlada de oxicodona
|
|
KR20050034645A
(ko)
*
|
2002-05-31 |
2005-04-14 |
알자 코포레이션 |
다양한 용량의 옥시코돈을 삼투 전달하기 위한 제형 및조성물
|
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
|
MXPA05001184A
(es)
*
|
2002-07-29 |
2005-09-12 |
Johnson & Johnson |
Formulaciones y formas de dosificacion para administracion controlada de topiramato.
|
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
JP2006522016A
(ja)
*
|
2003-01-14 |
2006-09-28 |
アルザ・コーポレーシヨン |
改変された粘度の層を用いる方法および投薬形態物
|
|
JP2006517593A
(ja)
*
|
2003-02-11 |
2006-07-27 |
アルザ・コーポレーシヨン |
投薬形態物の層形状修飾方法およびそのような修飾を受けさせた投薬形態物
|
|
DE102004032051A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
US20070048228A1
(en)
*
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
US20050058707A1
(en)
*
|
2003-08-06 |
2005-03-17 |
Iran Reyes |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
|
BRPI0413361B8
(pt)
*
|
2003-08-06 |
2021-05-25 |
Gruenenthal Gmbh |
comprimido seguro contra abuso termo-moldado por extrusão sem descoramento
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
JP2007503389A
(ja)
*
|
2003-08-22 |
2007-02-22 |
アルザ・コーポレーシヨン |
長期間にわたるトピラメートの段階的送達
|
|
DE602004032149D1
(de)
*
|
2003-09-26 |
2011-05-19 |
Alza Corp |
Oros-push-stick für die kontrollierte abgabe von wirkstoffen
|
|
JP5563731B2
(ja)
*
|
2003-09-26 |
2014-07-30 |
アルザ・コーポレーシヨン |
オピオイドおよび非オピオイド鎮痛薬の制御放出製剤
|
|
JP4919801B2
(ja)
*
|
2003-09-26 |
2012-04-18 |
アルザ・コーポレーシヨン |
高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法
|
|
EP1667663A1
(en)
*
|
2003-09-26 |
2006-06-14 |
Alza Corporation, c/o Johnson & Johnson |
Osmotic dosage forms for controlled delivery of alprazolam
|
|
CN1905856A
(zh)
*
|
2003-12-23 |
2007-01-31 |
阿尔扎公司 |
用于增加受控递送的药物组合物的溶解度的方法和剂型
|
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
|
JP2007517061A
(ja)
*
|
2003-12-29 |
2007-06-28 |
アルザ・コーポレーシヨン |
新規薬剤組成物及び投与形態物
|
|
MXPA06007510A
(es)
*
|
2003-12-29 |
2009-06-10 |
Johnson & Johnson |
Composiciones de farmaco y formas de dosis novedosas de topiramato.
|
|
DE102004032103A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
DE102004032049A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
WO2006023286A2
(en)
*
|
2004-08-19 |
2006-03-02 |
Alza Corporation |
Controlled release nanoparticle active agent formulation dosage forms and methods
|
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
DE102005005449A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
US7959938B2
(en)
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
|
US8778395B2
(en)
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
|
US20070077309A1
(en)
*
|
2005-09-30 |
2007-04-05 |
Wong Patrick S |
Banded controlled release nanoparticle active agent formulation dosage forms and methods
|
|
ES2747956T3
(es)
*
|
2005-12-30 |
2020-03-12 |
Rdd Pharma Ltd |
Dispositivo para tratar el esfínter anal
|
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
US9011930B2
(en)
*
|
2006-05-01 |
2015-04-21 |
Zycal Bioceuticals Healthcare Company, Inc. |
Nutritional supplement and use thereof
|
|
MX2008014870A
(es)
|
2006-05-30 |
2009-02-12 |
Intarcia Therapeutics Inc |
Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
|
|
CA2670821C
(en)
|
2006-08-09 |
2012-05-15 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
US7538652B2
(en)
*
|
2006-08-29 |
2009-05-26 |
International Business Machines Corporation |
Electrical component tuned by conductive layer deletion
|
|
DE102007011485A1
(de)
*
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
|
AU2008244523B2
(en)
|
2007-04-23 |
2012-02-16 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
|
JP5774853B2
(ja)
*
|
2008-01-25 |
2015-09-09 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
医薬投薬形
|
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
|
WO2009102467A2
(en)
|
2008-02-13 |
2009-08-20 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
DK2273983T3
(en)
*
|
2008-05-09 |
2016-09-19 |
Gruenenthal Gmbh |
A process for the preparation of a powdery formulation intermediate and a fixed final dosage form using a sprøjtestørkningstrin
|
|
US8715706B2
(en)
|
2009-06-18 |
2014-05-06 |
RDD Pharma, Ltd. |
Methods and devices for delivery of pharmaceutical agents within orifices of the body
|
|
RU2015138422A
(ru)
|
2009-07-22 |
2018-12-25 |
Грюненталь Гмбх |
Стабильная при окислении, прочная на излом лекарственная форма
|
|
TW201105316A
(en)
|
2009-07-22 |
2011-02-16 |
Gruenenthal Gmbh |
Hot-melt extruded pharmaceutical dosage form
|
|
US9053844B2
(en)
*
|
2009-09-09 |
2015-06-09 |
Littelfuse, Inc. |
Geometric configuration or alignment of protective material in a gap structure for electrical devices
|
|
CN107638562B
(zh)
|
2009-09-28 |
2022-12-02 |
精达制药公司 |
基本稳态药物递送的快速建立和/或终止
|
|
US9579285B2
(en)
*
|
2010-02-03 |
2017-02-28 |
Gruenenthal Gmbh |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
|
MX2013002293A
(es)
|
2010-09-02 |
2013-05-09 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
|
|
JP5925779B2
(ja)
|
2010-09-02 |
2016-05-25 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
無機塩を含む不正使用抵抗性剤形
|
|
CA2850468C
(en)
|
2010-09-28 |
2019-08-13 |
Depomed, Inc. |
Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
CN103841964A
(zh)
|
2011-07-29 |
2014-06-04 |
格吕伦塔尔有限公司 |
提供药物立即释放的抗破碎片剂
|
|
WO2013017242A1
(en)
|
2011-07-29 |
2013-02-07 |
Grünenthal GmbH |
Tamper-resistant tablet providing immediate drug release
|
|
JP6117249B2
(ja)
|
2012-02-28 |
2017-04-19 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
|
|
WO2013156453A1
(en)
|
2012-04-18 |
2013-10-24 |
Grünenthal GmbH |
Tamper resistant and dose-dumping resistant pharmaceutical dosage form
|
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
|
US20140088345A1
(en)
*
|
2012-09-27 |
2014-03-27 |
Palo Alto Research Center Incorporated |
Single channel, multiple drug delivery device and methods
|
|
MX2015016254A
(es)
|
2013-05-29 |
2016-04-20 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
|
|
BR112015026549A2
(pt)
|
2013-05-29 |
2017-07-25 |
Gruenenthal Gmbh |
forma de dosagem à prova de violação contendo uma ou mais partículas
|
|
CA2917136C
(en)
|
2013-07-12 |
2022-05-31 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
|
|
CN105934241B
(zh)
|
2013-11-26 |
2020-06-05 |
格吕伦塔尔有限公司 |
通过低温研磨制备粉末状药物组合物
|
|
JP7064285B2
(ja)
*
|
2013-12-06 |
2022-05-10 |
デュレクト コーポレーション |
抗酸化剤を含む組成物、流体分注器、及びそれらに関わる方法
|
|
US9297083B2
(en)
|
2013-12-16 |
2016-03-29 |
Palo Alto Research Center Incorporated |
Electrolytic gas generating devices, actuators, and methods
|
|
US20150320690A1
(en)
|
2014-05-12 |
2015-11-12 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
|
US9872835B2
(en)
|
2014-05-26 |
2018-01-23 |
Grünenthal GmbH |
Multiparticles safeguarded against ethanolic dose-dumping
|
|
US9801660B2
(en)
|
2014-07-31 |
2017-10-31 |
Palo Alto Research Center Incorporated |
Implantable fluid delivery devices, systems, and methods
|
|
US10278675B2
(en)
|
2014-07-31 |
2019-05-07 |
Palo Alto Research Center Incorporated |
Implantable estrus detection devices, systems, and methods
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
MX2017013637A
(es)
|
2015-04-24 |
2018-03-08 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
|
|
JP6993235B2
(ja)
|
2015-06-03 |
2022-01-13 |
インターシア セラピューティクス,インコーポレイティド |
インプラントの設置及び撤去システム
|
|
EP3346991A1
(en)
|
2015-09-10 |
2018-07-18 |
Grünenthal GmbH |
Protecting oral overdose with abuse deterrent immediate release formulations
|
|
TWI754643B
(zh)
|
2016-05-16 |
2022-02-11 |
美商因塔希亞治療公司 |
升糖素受體選擇性多肽和彼之使用方法
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
WO2018129058A1
(en)
|
2017-01-03 |
2018-07-12 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
|
|
US9707217B1
(en)
|
2017-02-03 |
2017-07-18 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dose-dumping resistant controlled release dosage form
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
|
WO2022124914A1
(en)
|
2020-12-08 |
2022-06-16 |
Ruminant Biotech Corp Limited |
Improvements to devices and methods for delivery of substances to animals
|